TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine

被引:79
作者
Babiuk, S
Mookherjee, N
Pontarollo, R
Griebel, P
Littel-Van den Hurk, SV
Hecker, R
Babiuk, L
机构
[1] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK S7N 5E3, Canada
[2] Pyxis Genom Canada, Saskatoon, SK, Canada
[3] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada
[4] Qiagen GmbH, Hilden, Germany
关键词
CpG; DNA vaccine; gene expression; TLR9;
D O I
10.1111/j.1365-2567.2004.01938.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasmid DNA continues to attract interest as a potential vaccine-delivery vehicle. However, the mechanisms whereby immune responses are elicited by plasmids are not fully understood. Although there have been suggestions regarding the importance of CpG motifs in plasmid immunogenicity, the molecular mechanisms by which CpG motifs enhance immune responses to DNA vaccines are not well understood. As Toll-like receptor 9-deficient (TLR9(-/-)) mice fail to respond to the adjuvant effects of CpG oligonucleotides, we used these mice to determine the effect of CpG motifs in plasmids used for DNA immunization. In the study described below, we report that DNA immunization was as effective in eliciting antigen-specific antibody and at stimulating antigen-specific interferon-gamma (IFN-gamma)-secreting cells in TLR9(-/-) mice as in TLR9(+/+) mice. This study illustrates that DNA vaccines elicit immune responses by multiple mechanisms and demonstrates that TLR9 is not essential for the induction of immune responses following DNA immunization.
引用
收藏
页码:114 / 120
页数:7
相关论文
共 29 条
[1]   Immunogenicity of bovine herpesvirus 1 glycoprotein D in mice: Effect of antigen form on the induction of cellular and humoral immune responses [J].
BacaEstrada, ME ;
Snider, M ;
Tikoo, SK ;
Harland, R ;
Babiuk, LA ;
LittelVandenHurk, SV .
VIRAL IMMUNOLOGY, 1996, 9 (01) :11-22
[2]   Effect of IL-4 and IL-12 liposomal formulations on the induction of immune response to bovine herpesvirus type-1 glycoprotein D [J].
BacaEstrada, ME ;
Foldvari, M ;
Snider, M ;
LittelvandenHurk, SV ;
Babiuk, LA .
VACCINE, 1997, 15 (16) :1753-1760
[3]   Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition [J].
Bauer, S ;
Kirschning, CJ ;
Häcker, H ;
Redecke, V ;
Hausmann, S ;
Akira, S ;
Wagner, H ;
Lipford, GB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9237-9242
[4]   CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity [J].
Chu, RS ;
Targoni, OS ;
Krieg, AM ;
Lehmann, PV ;
Harding, CV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) :1623-1631
[5]   Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein [J].
Deml, L ;
Bojak, A ;
Steck, S ;
Graf, M ;
Wild, J ;
Schirmbeck, R ;
Wolf, H ;
Wagner, R .
JOURNAL OF VIROLOGY, 2001, 75 (22) :10991-11001
[6]   A Toll-like receptor recognizes bacterial DNA [J].
Hemmi, H ;
Takeuchi, O ;
Kawai, T ;
Kaisho, T ;
Sato, S ;
Sanjo, H ;
Matsumoto, M ;
Hoshino, K ;
Wagner, H ;
Takeda, K ;
Akira, S .
NATURE, 2000, 408 (6813) :740-745
[7]   The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus emulsigen arc increased by formulation with CpG oligodeoxynucleotides [J].
Ioannou, XP ;
Griebel, P ;
Hecker, R ;
Babiuk, LA ;
Littel-van den Hurk, SV .
JOURNAL OF VIROLOGY, 2002, 76 (18) :9002-9010
[8]   Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes [J].
Kim, JJ ;
Nottingham, LK ;
Wilson, DM ;
Bagarazzi, ML ;
Tsai, A ;
Morrison, LD ;
Javadian, A ;
Chalian, AA ;
Agadjanyan, MG ;
Weiner, DB .
VACCINE, 1998, 16 (19) :1828-1835
[9]  
Klinman DM, 1997, J IMMUNOL, V158, P3635
[10]   Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine [J].
Kojima, Y ;
Xin, KQ ;
Ooki, T ;
Hamajima, K ;
Oikawa, T ;
Shinoda, K ;
Ozaki, T ;
Hoshino, Y ;
Jounai, N ;
Nakazawa, M ;
Klinman, D ;
Okuda, K .
VACCINE, 2002, 20 (23-24) :2857-2865